📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Enhancing the Transdermal Delivery of 'Next Generation' Variable New Antigen Receptors Using Microarray Patch Technology: a Proof-of-Concept Study. (2022)

First Author: Hutton ARJ

Attributed to: Targeting the pathogenic Th17 cell axis in autoimmunity:developing a portfolio of novel, rationally designed and innovatively delivered biologics funded by UKRI FLF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.xphs.2022.08.027

PubMed Identifier: 36037879

Publication URI: http://europepmc.org/abstract/MED/36037879

Type: Journal Article/Review

Volume: 111

Parent Publication: Journal of pharmaceutical sciences

Issue: 12

ISSN: 0022-3549